Summary
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall under the NINDS mission. Therapeutic agents include small molecules, biologics or biotechnology-derived products. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network or other translational programs.
Eligibility
- Public and State Institutions of Higher Education
- Small Businesses
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- Nonprofits Non Higher Education Without 501c3
- Independent School Districts
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
- State Governments
- City Or Township Governments
- Special District Governments
- Public and Indian Housing Authorities
- Native American Tribal Governments Federally Recognized
- County Governments
- Other
- Private Institutions of Higher Education
- For Profit Organizations Other Than Small Businesses
Funding categories
- Health
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record